Skip to content

The effectiveness of paradox therapy on cancer

Evaluating the effectiveness of paradox therapy for the treatment of fear of cancer recurrence, anxiety of death and adherence to treatment in female cancer patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240616062151N1
Enrollment
52
Registered
2025-05-14
Start date
2025-05-10
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fear of cancer recurrence

Interventions

Intervention 1: Intervention group: Intervention group: Paradox therapy method. Paradox is the administration of the same symptom. In the paradox therapy model using the PTC method, the same symptom i

Sponsors

University of Tehran
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Women suffering from all types of cancer2. Age 18 and above3. Being in all stages of treatment except the last stage4. Attending active treatment or follow-up treatment5. Not having a history of psychiatric illness6. Not having concurrent physical illness7. Being literate in reading and writing8. Proficient in Persian language9. Being healthy in terms of consciousness

Exclusion criteria

Exclusion criteria: Announcing withdrawal from participating in the research2. More than two absence therapy sessions3. Drug abuse4. Using complementary and alternative medicine methods

Design outcomes

Primary

MeasureTime frame
Adherence to Treatment. Timepoint: Before the intervention, after the end of the intervention and one month after the end of the intervention. Method of measurement: Fatemi Treatment Compliance Questionnaire.;Fear of cancer recurrence. Timepoint: Before the intervention, after the end of the intervention and one month after the end of the intervention. Method of measurement: Simard and Savard Fear of Relapse Questionnaire.;Death anxiety. Timepoint: Before the intervention, after the end of the intervention and one month after the end of the intervention. Method of measurement: Anxiety over the death of Templar.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Manijeh Firouzi

University of Tehran

mfiroozy@ut.ac.ir+98 21 6111 7480

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026